Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User – Global Forecast to 2019

Publisher Name :
Date: 29-Sep-2014
No. of pages: 200

In this report, the global epigenetics market is segmented on the basis of products, research areas, and end users. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The subsegments of the enzymes product segment are DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes). The subsegments of the instruments & consumables product segment are mass spectrometers; next-generation sequencers; qPCRs; sonicators; and other epigenetics instruments & consumables. The subsegments of the kits product segment are bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The subsegments of the reagents product segment are antibodies; buffers; histones; magnetic beads; primers; and other epigenetics reagents.

Epigenetics has applications in a large number of research areas. On the basis of research areas, the report is segmented into developmental biology, drug discovery, oncology, and other epigenetics research areas. On the basis of end users, the global epigenetics market report is segmented into academic research institutes, biotechnology and pharmaceutical companies, and contract research organizations. The geographic segments included in this report are Asia, Europe, North America, and Rest of the World.

The key driver for this market is growth in cancer prevalence. The rising incidence of this disease has prompted increased research interest and funding for research. Furthermore, as epigenetics has shown potential for the development of new therapeutic products for diseases like cancer, partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based therapeutics products have increased, leading to intensified R&D activities in this field; all factors that will aid the growth of the global epigenetics market.

In this report, a combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their epigenetics segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the epigenetics market. The competitive landscape covers growth strategies adopted by industry players over the last three years. It also includes analysis of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the epigenetics market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the epigenetics market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the epigenetics market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various epigenetics products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the epigenetics market

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User – Global Forecast to 2019

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope

2 Research Methodology
2.1 Description of the Epigenetics Demand Model
2.1.1 Growth in R&D Expenditure
2.1.2 High Prevalence of Cancer
2.1.3 Increasing Number of Biotechnology Patents
2.2 Market Size Estimation
2.3 Market Crackdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.2.1 Key Industry Insights
2.4.3 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Lucrative Market Opportunities in Epigenetics Market Globally
4.2 Life Cycle Analysis, By Geography

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Epigenetics Market By Product
5.2.2 Epigenetics Market By Research Areas
5.2.3 Market By End Users
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Cancer to Propel Growth of Epigenetics Market
5.3.1.2 Increased Funding to Fuel Market Growth
5.3.1.3 Increased Intensity of Research Activities to Drive the Market
5.3.1.4 Increased Application for Non-Oncology Diseases
5.3.1.5 Growing Partnership Between Academic, Biotechnology & Pharmaceutical Companies for Epigenetics-Based Products
5.3.2 Restraints
5.3.2.1 High Cost of Instruments Would Restrain Investments in Epigenetics Market
5.3.2.2 Lack of Trained Professionals Would Hinder the Growth of the Market
5.3.3 Opportunities
5.3.3.1 Emerging Markets Present Significant Opportunities for Epigenetics

6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.2.1 Key Influencers
6.3 Porter’s Five forces Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat From Substitutes
6.3.3 Bargaining Power of Buyers
6.3.4 Bargaining Power of Suppliers
6.3.5 Competitive Rivalry Among Existing Player
6.4 Strategic Benchmarking
6.4.1 New Product Launces and Product Enhancements

7 Epigenetics Market, By Product
7.1 Introduction
7.2 Enzymes
7.2.1 Dna-Modifying Enzymes
7.2.2 Protein-Modifying Enzymes
7.2.3 RNA-Modifying Enzymes
7.3 Instruments & Consumables
7.3.1 Mass Spectrometers
7.3.2 Next-Generation Sequencers
7.3.3 Qpcrs
7.3.4 Sonicators
7.3.5 Other Epigenetics Instruments & Consumables
7.4 Kits
7.4.1 Bisulfite Conversion Kits
7.4.2 Chip-SEQ Kits
7.4.3 RNA Sequencing Kits
7.4.4 Whole Genome Amplification Kits
7.4.5 5-HMC & 5-MC Analysis Kits
7.4.6 Other Epigenetics Kits
7.5 Reagents
7.5.1 Antibodies
7.5.2 Buffers
7.5.3 Histones
7.5.4 Magnetic Beads
7.5.5 Primers
7.5.6 Other Epigenetics Reagents

8 Epigenetics Market, By Research Areas
8.1 Introduction
8.2 Developmental Biology
8.3 Drug Discovery
8.4 Oncology
8.5 Other Research Areas

9 Market, By End User
9.1 Introduction
9.2 Academic Research Institutes
9.3 Biotechnology & Pharmaceutical Companies
9.4 Contract Research Organizations

10 Geographic Analysis
10.1 Introduction
10.2 Asia
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 Rest of Asia
10.3 Europe
10.3.1 France
10.3.2 Germany
10.3.3 Italy
10.3.4 Spain
10.3.5 U.K.
10.3.6 Roe
10.4 North America
10.4.1 Canada
10.4.2 U.S.
10.5 ROW
10.5.1 Middle East and Africa
10.5.2 Pacific and Oceania
10.5.3 South America

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, Epigenetics Enzymes, Kits, and Regents Market
11.3 Market Share Analysis, Epigenetics Instruments and Consumables Market
11.4 Competitive Situation and Trends
11.4.1 New Product Launches
11.4.2 Agreements, Partnerships, and Collaborations
11.4.3 Acquisitions
11.4.4 Expansions
11.4.5 Other Developments

12 Company Profiles
12.1 Introduction
12.2 Abcam
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Key Strategy
12.2.4 Recent Developments
12.2.5 SWOT Analysis
12.2.6 MNM View
12.3 Illumina
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Key Strategy
12.3.4 Recent Developments
12.3.5 SWOT Analysis
12.3.6 MNM View
12.4 New England Biolabs
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Key Strategy
12.4.4 Recent Developments
12.4.5 SWOT Analysis
12.4.6 MNM View
12.5 Sigma-Aldrich Corporation
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Key Strategy
12.5.4 Recent Developments
12.5.5 SWOT Analysis
12.5.6 MNM View
12.6 Thermo Fisher Scientific
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Key Strategy
12.6.4 Recent Developments
12.6.5 SWOT Analysis
12.6.6 MNM View
12.7 Active Motif
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Key Strategy
12.7.4 Recent Development
12.8 Diagenode
12.8.1 Business Overview
12.8.2 Product Portfolio
12.8.3 Key Strategy
12.8.4 Recent Developments
12.9 Merck
12.9.1 Business Overview
12.9.2 Product Portfolio
12.9.3 Key Strategy
12.9.4 Recent Developments
12.10 Qiagen
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Key Strategy
12.10.4 Recent Developments
12.11 Zymo Research
12.11.1 Business Overview
12.11.2 Product Portfolio
12.11.3 Key Strategy
12.11.4 Recent Developments

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables

Table 1 Epigenetics Market Size, By Product, 2012–2019 ($Million)
Table 2 Epigenetics Enzymes Market Size, By Type, 2012–2019 ($Million)
Table 3 Epigenetics Enzymes Market Size, By Region, 2012–2019 ($Million)
Table 4 Representative List of Dna-Modifying Enzymes
Table 5 Epigenetics Dna-Modifying Enzymes Market Size, By Region, 2012–2019 ($Million)
Table 6 Representative List of Protein-Modifying Enzymes
Table 7 Epigenetics Protein-Modifying Enzymes Market Size, By Region, 2012–2019 ($Million)
Table 8 Representative List of RNA-Modifying Enzymes
Table 9 Epigenetics RNA-Modifying Enzymes Market Size, By Region, 2012–2019 ($Million)
Table 10 Epigenetics Instruments & Consumables Market Size, By Type, 2012–2019 ($Million)
Table 11 Epigenetics Instruments & Consumables Market Size, By Region, 2012–2019 ($Million)
Table 12 Mass Spectrometers Instruments & Consumables Market Size, By Region, 2012–2019 ($Million)
Table 13 Next-Generation Sequencers Instruments & Consumables Market Size,By Region, 2012–2019 ($Million)
Table 14 Qpcrs Instruments & Consumables Market Size, By Region, 2012–2019 ($Million)
Table 15 Sonicators Instruments & Consumables Market Size, By Region, 2012–2019 ($Million)
Table 16 Other Epigenetics Instruments and Consumables Market Size, By Region, 2012–2019 ($Million)
Table 17 Epigenetics Kits Market Size , By Type, 2012–2019 ($Million)
Table 18 Epigenetics Kits Market Size, By Region, 2012–2019 ($Million)
Table 19 Bisulfite Conversion Kits Market Size, By Region, 2012–2019 ($Million)
Table 20 Chip-SEQ Kits Market Size, By Region, 2012–2019 ($Million)
Table 21 RNA Sequencing Kits Market Size, By Region, 2012–2019 ($Million)
Table 22 Whole Genome Amplification Kits Market Size, By Region, 2012–2019 ($Million)
Table 23 5-HMC & 5-MC Kits Market Size, By Region 2012–2019 ($Million)
Table 24 Other Epigenetics Kits Market Size, By Region, 2012–2019 ($Million)
Table 25 Epigenetics Reagents Market, By Type, 2012–2019 ($Million)
Table 26 Epigenetics Reagents Market Size, By Region 2012–2019 ($Million)
Table 27 Antibodies Reagents Market Size, By Region, 2012–2019 ($Million)
Table 28 Buffers Reagents Market Size, By Region, 2012–2019 ($Million)
Table 29 Histones Reagents Market Size, By Region, 2012–2019 ($Million)
Table 30 Magnetic Beads Reagents Market Size, By Region 2012–2019 ($Million)
Table 31 Primers Reagents Market Size, By Region, 2012–2019 ($Million)
Table 32 Other Epigenetics Reagents Market Size, By Region, 2012–2019 ($Million)
Table 33 Epigenetics Market, By Research Area, 2012–2019 ($Million)
Table 34 Market for Developmental Biology, By Region, 2012–2019 ($Million)
Table 35 Market for Drug Discovery, By Region, 2012–2019 ($Million)
Table 36 Market Size for Oncology, By Region, 2012–2019 ($Million)
Table 37 Molecular Aetiology of Disease Syndromes
Table 38 Market Size for Other Research Areas, By Region, 2012–2019 ($Million)
Table 39 Epigenetics Market, By End User, 2012–2019 ($Million)
Table 40 Market for Academic Research Institutes, By Region, 2012–2019 ($Million)
Table 41 Market Size for Biotechnology & Pharmaceutical Companies,By Region, 2012–2019 ($Million)
Table 42 Market Size for Contract Research Organizations, By Region, 2012–2019 ($Million)
Table 43 Market, By Geography, 2012–2019 ($Million)
Table 44 Asia: Epigenetics Market, By Geography, 2012–2019 ($Million)
Table 45 Asia: Market, By End User, 2012–2019 ($Million)
Table 46 Asia: Market, By Product, 2012–2019 ($Million)
Table 47 Asia: Epigenetics Enzymes Market, Bytype, 2012–2019 ($Million)
Table 48 Asia: Epigenetics Instruments & Consumbales Market, By Type, 2012–2019 ($Million)
Table 49 Asia: Epigenetics Kits Market, By Type, 2012–2019 ($Million)
Table 50 Asia: Epigenetics Reagents Market, By Type, 2012–2019 ($Million)
Table 51 Asia: Market, By Research Area, 2012–2019 ($Million)
Table 52 Europe: Market, By Geography, 2012–2019 ($Million)
Table 53 Europe: Market, By End User, 2012–2019 ($Million)
Table 54 Europe: Market, By Product, 2012–2019 ($Million)
Table 55 Europe: Epigenetics Enzymes Market, Bytype, 2012–2019 ($Million)
Table 56 Europe: Epigenetics Instruments & Consumbales Market, By Type, 2012–2019 ($Million)
Table 57 Europe: Epigenetics Kits Market, By Type, 2012–2019 ($Million)
Table 58 Europe: Epigenetics Reagents Market, By Type, 2012–2019 ($Million)
Table 59 Europe: Market, By Research Area, 2012–2019 ($Million)
Table 60 North America: Epigenetics Market, By Geography, 2012–2019 ($Million)
Table 61 North America: Market, By End User, 2012–2019 ($Million)
Table 62 North America: Market, By Product, 2012–2019 ($Million)
Table 63 North America: Epigenetics Enzymes Market, Bytype, 2012–2019 ($Million)
Table 64 North America: Epigenetics Instruments & Consumbales Market, By Type, 2012–2019 ($Million)
Table 65 North America: Epigenetics Kits Market, By Type, 2012–2019 ($Million)
Table 66 North America: Epigenetics Reagents Market, By Type, 2012–2019 ($Million)
Table 67 North America: Market, By Research Area, 2012–2019 ($Million)
Table 68 ROW: Epigenetics Market, By Geography, 2012–2019 ($Million)
Table 69 ROW: Market, By End User, 2012–2019 ($Million)
Table 70 ROW: Market, By Product, 2012–2019 ($Million)
Table 71 ROW: Epigenetics Enzymes Market, Bytype, 2012–2019 ($Million)
Table 72 ROW: Epigenetics Instruments & Consumbales Market, By Type, 2012–2019 ($Million)
Table 73 ROW: Epigenetics Kits Market, By Type, 2012–2019 ($Million)
Table 74 ROW: Epigenetics Reagents Market, By Type, 2012–2019 ($Million)
Table 75 ROW: Market, By Research Area, 2012–2019 ($Million)
Table 76 New Product Launches, 2011–2014
Table 77 Agreements, Collaborations, and Partnerships, 2011–2014
Table 78 Acquisitions, 2011–2014
Table 79 Expansions, 2011–2014
Table 80 Other Developments, 2011–2014

List of Figures

Figure 1 Global Epigenetics Market
Figure 2 Research Methodology
Figure 3 Increased R&D Expenditure on Epigenetics Will Drive the Global Market
Figure 4 Increasing Incidence of Cancer to Fuel the Epigenetics Market
Figure 5 Increasing Number of Biotechnology Patents Reflect the Increased Research in the Epigenetics Market
Figure 6 Bottom-Up Approach
Figure 7 Market Size Estimation Methodology: top-Down Approach
Figure 8 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 9 DNA-Modifying Enzymes is the Largest Segment in the Epigenetics Enzymes Market and is Expected to Grow At the Highest Rate in the Coming Years
Figure 10 Next-Generation Sequencers is the Largest Segment in the Epigenetics Instruments & Consumables Market and is Expected to Grow At the Highest Rate By 2019
Figure 11 Whole Genome Amplification Kits is Expected to Grow At the Highest Rate in the Epigenetics Kits Market
Figure 12 Antibodies is the Largest Epigenetics Reagents Segment Owing to increased Usage of Epigenetics in Biomarker Discovery
Figure 13 Oncology is the Largest Reserch Area for Epigenetics Owing to Increasing Prevalence of Cancer Across the Globe
Figure 14 Academic Research Institutes Accounted for the Largest End-User Segment Owing to Increased Research in Epigenetics
Figure 15 North America Accounts for the Largest Market Share in the Global Epigenetics Market in 2014
Figure 16 Prevalence of Cancer, Increasing Research to Drive Market Growth
Figure 17 Kits Segment to Account for Maximum Market Share Globally
Figure 18 Kits Segment Will Continue to Dominate Epigenetics Market in Next Five Years
Figure 19 Academic Research Institutes Will Be the Largest End-User Segment for Next Five Years
Figure 20 Asia to Grow At the Highest Pace During the forecast Period
Figure 21 Drug Discovery Research to Hold Lucrative Growth Opportunities for Market
Figure 22 Asian Market Holds Lucrative Growth Opportunities
Figure 23 Market Segmentation: By Product
Figure 24 Market Segmentation: By Research Area
Figure 25 Market Segmentation: By End User
Figure 26 High Prevalence of Cancer to Boost the Growth of Epigenetics Market
Figure 27 Supply Chain – Reference
Figure 28 Porter’s Five forces Analysis – Reference
Figure 29 Strategic Bench Marking: New England Biolabs and thermo Fisher Scientific Adopted Organic Growth Strtaegies of New Product Launches and Product Enhancements
Figure 30 Epigenetics Market, By Product
Figure 31 Kits Account for the Largest Share of the Market in 2014
Figure 32 Epigenetics Enzyme S Market, By Type
Figure 33 Dna-Modifying Enzymes Will Be the Fastest-Growing Segment in the Epigenetics Enzymes Market
Figure 34 Epigenetics Enzymes Market Size, By Type, 2014 (Market Size and Growth Rates)
Figure 35 North America Accounts for the Largest Share in Dna-Modifying Enzymes
Figure 36 Protein-Modifying Enzymes to Witness Highest Growth Rate in Asia
Figure 37 RNA-Modifying Enzymes to Grow At the Highest Cagr in Asia During the forecast Period
Figure 38 Epigenetics Products Market, By Instruments & Consumables Market, By Type
Figure 39 Next-Generation Sequencers Are Expected to Grow At the Highest Rate in 2014
Figure 40 North America to Account for the Largest Share in Epigenetics Mass Spectrometers By 2019
Figure 41 Next-Generation Sequencers to Witness Highest Growth Rate in Epigenetics Instruments & Consumables Market for North America
Figure 42 Asia is Expected to Grow At the Highest Rate for Qpcrs By 2019
Figure 43 Asia is Expected to Grow At the Highest Rate for Sonicators in the Global Epigenetics Instruments & Consumables Market
Figure 44 North America is Expected to Account for the Largest Share of the Global Market for Other Instruments and Consumables By 2019
Figure 45 Epigenetics Kits Market, By Type
Figure 46 Whole Genome Amplification Kits Are Expected to Grow At the Highest Rate By 2019
Figure 47 North America is Expected to Account for the Largest Market Share for Bisulfite Conversion Kits By 2019
Figure 48 North America Accounted for the Largest Share of Chip-SEQ Kits in 2014
Figure 49 RNA Sequencing Kits to Witness Highest Growth Rate in Asia By 2019
Figure 50 North America to Witness Highest Growth Rate for Whole Genome Amplification Kits By 2019
Figure 51 5-HMC & 5-MC Analysis Kits to Grow At the Highest Growth Rate in Asia By 2019
Figure 52 Asia to Witness Highest Growth in Other Epigenetics Kits Market
Figure 53 Epigenetics Reagents Market, By Type
Figure 54 Antibodies Accounted for the Largest Market Share in the Epigenetics Reagents Market in 2014
Figure 55 Antibodies to Grow At the Highest Rate in Asia
Figure 56 North America Accounted for the Largest Share in This Market
Figure 57 Histones to Witness High Growth Rate in Asia By 2019
Figure 58 North America is Expected to Account for the Largest Share in Magnetic Beads By 2019
Figure 59 Primers is Expected to Account for the Largest Share in North America By 2019
Figure 60 Other Epigenetics Reagents to Witness High Growth Rate in Asia By 2019
Figure 61 Epigenetics Market, By Research Area
Figure 62 Epigenetics Market Size, By Research Area, 2014 (Market Size and Growth Rates)
Figure 63 Drug Discovery Will Be Fastest-Growing Research Area in Epigenetics Market
Figure 64 Increased Research in Epigenetics of Developmental Biology to Aid Market Growth
Figure 65 North America Commands Largest Share of Developmental Biology Segment, Owing to Strong Research Activity in This Field
Figure 66 Increased Collaboration Between Biotech, Pharmaceutical Companies to Drive Market Growth
Figure 67 Increased Prevalence of Cancer to Drive the Market
Figure 68 Increase Funding for Cancer Epigenetics Will Drive the Global Market
Figure 69 Other Epigenetic Research Segment to Witness Highest Growth Rate in Asia
Figure 70 Epigenetics Market, By End User
Figure 71 Market Size, By End User, 2014 (Market Size and Growth Rates)
Figure 72 Biotechnology & Pharmaceutical Companies Will Be the Fastest-Growing End-User Segment By 2019
Figure 73 Public-Private Partnership Will Drive the Research in Epigenetics
Figure 74 Collaborations Between Drug Discovery and Biotechnology Companies to Fuel Market Growth
Figure 75 Asian Cro End-User Market Expected to Grow At Highest Rate Owing to Cheaper Outsourcing Services
Figure 76 Geographic Snapshot (2014)
Figure 77 Asia Market Snapshot
Figure 78 Asia: Epigenetics Market – By Product
Figure 79 Asia: Epigenetics Market – By Product
Figure 80 China: Epigenetics Market – By Product
Figure 81 India: Epigenetics Market – By Product
Figure 82 Japan: Epigenetics Market – By Product
Figure 83 Roa: Epigenetics Market – By Product
Figure 84 Europe Market Snapshot
Figure 85 Europe: Epigenetics Market – By Product
Figure 86 Europe: Epigenetics Market – By Product
Figure 87 France: Epigenetics Market – By Product
Figure 88 Germany: Epigenetics Market – By Product
Figure 89 Italy: Epigenetics Market – By Product
Figure 90 Spain: Epigenetics Market – By Product
Figure 91 U.K.: Epigenetics Market – By Product
Figure 92 Roe: Epigenetics Market – By Product
Figure 93 North America Market Snapshot
Figure 94 North America: Epigenetics Market – By Product
Figure 95 North America: Epigenetics Market – By Product
Figure 96 Canada: Epigenetics Market – By Product
Figure 97 U.S.: Epigenetics Market – By Product
Figure 98 ROW Market Snapshot
Figure 99 ROW: Epigenetics Market – By Product
Figure 100 ROW: Epigenetics Market – By Product
Figure 101 Middle East Nad Africa: Epigenetics Market – By Product
Figure 102 Pacific and Oceania: Epigenetics Market – By Product
Figure 103 South America: Epigenetics Market – By Product
Figure 104 Product Innovations is the Key Strategy Adopted By Players in the Epigenetics Market
Figure 105 Global Epigenetics Enzymes, Kits, and Regents Market Share Analysis, By Key Player, 2014
Figure 106 Global Epigenetics Instruments and Consumables Market Share Analysis, By Key Player, 2014
Figure 107 Battle for Market Share: New Product Launches is the Key Strategy Adopted By Players Between 2011 and 2014
Figure 108 Geographic Revenue Mix of top 4 Market Players
Figure 109 Company Snapshot
Figure 110 SWOT Analysis
Figure 111 Company Snapshot
Figure 112 SWOT Analysis
Figure 113 SWOT Analysis
Figure 114 Company Snapshot
Figure 115 SWOT Analysis
Figure 116 Company Snapshot
Figure 117 SWOT Analysis
Figure 118 Company Snapshot
Figure 119 Company Snapshot

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) – Forecast to 2019
    Published: 29-Oct-2014        Price: US $4650 Onwards        Pages: 224
    The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell re......
  • Global Polymerase Chain Reaction (PCR) Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Polymerase Chain Reaction (PCR) is a technique of molecular genetics, which allows amplification and analysis of nucleic acid. It is very precise, specific and accurate technique used to amplify a specific DNA target from a mixture of DNA molecules. It is used in a wide array of applications in research and diagnosis, including genetic engineering, cloning, sequencing, diagnosis, genotyping, and many other areas. Advances in PCR technology and tools provide high reproducibility within a short pe......
  • RNA Interference Screening Trends 2014
    Published: 27-Oct-2014        Price: US $2500 Onwards        Pages: 53
    Executive Summary This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on RNA interference (RNAi) screening and gene silencing carried out in October 2014. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update our previous report in siRNA screening (published September 2012). The questionnaire was compiled to meet the needs, requirements and interests of the RNAi screening vendo......
  • TVAX Biomedical, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 29
    TVAX Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘TVAX Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TVAX Biomedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TVAX Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route......
  • Medisyn Technologies, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 29
    Medisyn Technologies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Medisyn Technologies, Inc. - Product Pipeline Review - 2014', provides an overview of the Medisyn Technologies, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Medisyn Technologies, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of......
  • GlycoVaxyn AG – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 30
    GlycoVaxyn AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘GlycoVaxyn AG - Product Pipeline Review - 2014', provides an overview of the GlycoVaxyn AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoVaxyn AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mol......
  • Biomay AG – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 33
    Biomay AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Biomay AG - Product Pipeline Review - 2014', provides an overview of the Biomay AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Biomay AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It a......
  • Vaxart, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 31
    Vaxart, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Vaxart, Inc. - Product Pipeline Review - 2014', provides an overview of the Vaxart, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxart, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecul......
  • Immunocore Limited – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 31
    Immunocore Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Immunocore Limited - Product Pipeline Review - 2014', provides an overview of the Immunocore Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immunocore Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs